Implementation expands
The Arkansas Insurance Department’s report dated November 20 puts implementation of the $10.50 additional generic dispensing cost at approximately 1,052 health benefit plans. The October 16 report put that figure at approximately 100. Both identify final determinations sent to 28 PBMs. The November report says plan appeals are being processed.12
The report’s first public posting time has not been confirmed. The development is the materially larger implementation count in the dated monthly report. It is not a new nationwide dispensing-fee requirement.123
Scope follows the applicable determination
Rule 128 permits the Commissioner to review pharmacy compensation and require an additional dispensing cost where the program does not provide fair and reasonable reimbursement sufficient for an adequate pharmacy network. The rule contains federal and state-law exemptions. A pharmacy should not infer from the aggregate count that every plan or prescription qualifies.3
Operational analysis
Chad’s analysis: drug acquisition reimbursement and payment for the professional work of dispensing should be evaluated separately. For an affected Arkansas business, identify the applicable plan determination, confirm its terms and reconcile the amounts actually paid. The larger implementation count shows broader use of this state framework; it does not by itself establish that individual pharmacies received every payment owed or that the fee covers their operating costs.123
Source notes
- Ark. Ins. Dep’t, Report from AID Concerning Rule 128: Fair and Reasonable Pharmacy Reimbursements 1 (Nov. 20, 2026).
- Ark. Ins. Dep’t, Report from AID Concerning Rule 128: Fair and Reasonable Pharmacy Reimbursements 1 (Oct. 16, 2026).
- Ark. Ins. Dep’t, Rule 128: Fair and Reasonable Pharmacy Reimbursements §§ III–IV, at 2–4 (codified at 23 Code Ark. Rules pt. 148).